JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

Home・Aandelen Lijst・Pulse Biosciences Inc

Pulse Biosciences Inc

Gesloten

SectorGezondheidszorg

13.83 2.52

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

13.61

Max

13.86

Belangrijke statistieken
By Trading Economics
Inkomsten	-217K -19M
Verkoop	86K 86K
EPS	-0.29
Winstmarge	-22,540.698
Werknemers	75
EBITDA	-228K -19M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+61.53% upside

Dividenden
By Dow Jones
Volgende Winsten	26 mrt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-179M 958M
Vorige openingsprijs	11.31
Vorige sluitingsprijs	13.83

Nieuwssentiment

By Acuity

34%

66%

94 / 352 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

16.59 / 17.17 Steun & Weerstand

Pulse Biosciences Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

30 jan 2026, 20:14 UTC

Acquisities, Fusies, Overnames

Reddy Ice to Buy Arctic Glacier, DOJ Requires Certain Divestitures

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Negotiations Over $100B OpenAI, Nvidia Deal Stall -- WSJ

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Nvidia, OpenAI in Talks to Revise Nature of Broader Partnership, Sources Say -- WSJ

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Nvidia CEO Jensen Huang Has Privately Told Colleagues That Deal Is Non-Binding, Sources Say -- WSJ

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Nvidia's Huang Has Privately Criticized OpenAI's Business Strategy, Sources Say -- WSJ

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

OpenAI, Nvidia Deal Talks Stalled in Recent Months, Sources Say -- WSJ

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Nvidia's Huang Expressed Concerns Over Competition OpenAI Faces From Anthropic, Google, Sources Say -- WSJ

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Nvidia Weighing Equity Investment of Tens of Billions of Dollars Into OpenAI, Sources Say -- WSJ

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Negotiations Over $100B OpenAI, Nvidia Deal Stall, Sources Say -- WSJ

30 jan 2026, 23:41 UTC

Marktinformatie

Deckers Outdoor Seen as Undervalued -- Market Talk

30 jan 2026, 23:12 UTC

Acquisities, Fusies, Overnames

Supreme Court of British Columbia Approves Fortescue Purchase of Alta Copper

30 jan 2026, 22:20 UTC

Winsten

Verizon Posts Strong Subscriber Gains Under New CEO -- WSJ

30 jan 2026, 22:10 UTC

Marktinformatie

Disney CEO's Exit Plan Marks Abrupt End to Messy Succession -- Market Talk

30 jan 2026, 21:50 UTC

Marktinformatie

Winsten

Tech, Media & Telecom Roundup: Market Talk

30 jan 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

30 jan 2026, 21:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

30 jan 2026, 21:42 UTC

Winsten

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

30 jan 2026, 21:36 UTC

Winsten

GE Aerospace and GE Vernova Issue Their Annual Reports. They Contain Messages for Investors. -- Barrons.com

30 jan 2026, 21:33 UTC

Winsten

Tesla Stock Rebounds From Earnings Dip. SpaceX Is Helping. -- Barrons.com

30 jan 2026, 20:42 UTC

Winsten

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

30 jan 2026, 20:37 UTC

Acquisities, Fusies, Overnames

Why a Ruling Over CK Hutchison's Panama Canal Ports Matters -- and What's Next -- WSJ

30 jan 2026, 20:20 UTC

Marktinformatie

Oil Posts Weekly Gains on U.S.-Iran Tensions -- Market Talk

30 jan 2026, 20:13 UTC

Marktinformatie

U.S. Natural Gas Futures Rise on Weather-Driven Demand -- Market Talk

30 jan 2026, 19:52 UTC

Winsten

Visa and Amex Results Point to a Strong Holiday Season for Retailers -- Barrons.com

30 jan 2026, 19:29 UTC

Marktinformatie

Winsten

KLA Guidance Only 'Tepid' as Memory Rally Favors Peers -- Market Talk

30 jan 2026, 19:09 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

30 jan 2026, 19:09 UTC

Marktinformatie

Next Canadian Inflation Release Pushed Back a Day to Not Clash With Holiday -- Market Talk

30 jan 2026, 19:07 UTC

Marktinformatie

Canada Performing Well Below Economic Potential -- Market Talk

30 jan 2026, 18:46 UTC

Winsten

'All Boats Are Rising' in Data and Memory, Says Western Digital's CFO. Just Look at the Stocks. -- Barrons.com

30 jan 2026, 18:34 UTC

Winsten

Exxon, Chevron Post Slimmest Annual Profits Since 2021 -- 2nd Update

Peer Vergelijking

Prijswijziging

Pulse Biosciences Inc Prognose

Koersdoel

By TipRanks

61.53% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 22 USD 61.53%

Hoogste 22 USD

Laagste 22 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Pulse Biosciences Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan Pulse Biosciences Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

16.59 / 17.17Steun & Weerstand

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

94 / 352 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.